Pedro Bueno is a partner at DNA Capital, based in São Paulo

He is CEO of the combined company formed by the merger of DASA (5th largest diagnostics company in the world) and Rede Ímpar (2nd largest Brazilian independent hospital chain), as well as a board member of both companies.

Pedro began his career in investment banking at BTG Pactual and worked on multiple M&A transactions. In 2012, he joined Amil and participated in the sale of the company to UnitedHealth Group, which was the largest investment ever made by a North American group in Brazil at the time. Subsequently, Pedro joined DASA as its CEO.

Pedro is currently an independent board member at Localiza and holds a B.A. in Economics from Pontifícia Universidade Católica do Rio de Janeiro.